KISS1R and ovarian carcinoma: We show in the present study of 518 ovarian cancer cases that kisspeptin and GPR54 immunoreactivity are very significantly associated with a clear cell carcinoma subtype, and that both kisspeptins and GPR54 are independent markers for favourable prognosis as determined by multivariable analysis.